Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

NCT06522334 is registered in ClinicalTrials.gov with Ludwig Boltzmann Institute for Lung Health as lead sponsor.

NCT NCT06522334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06522334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
Lead sponsor
Ludwig Boltzmann Institute for Lung Health
Phase
Observational
Overall status
Recruiting
Start date
February 28, 2024
Completion date
February 28, 2034
Enrollment
400 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease